ONA Therapeutics Strengthens Scientific Leadership Team
-
Industry veteran in oncology antibody discovery & development Dr Haijun Sun appointed Chief Scientific Officer
-
Expansion of the Scientific Advisory Board with appointments of leading experts in preclinical, translational and clinical drug development